Alithea Genomics

Alithea Genomics

Private
EpalingesHealthcare & Life Scienceshttps://alitheagenomics.com/

Last Round

Seed

Mar 4, 2026

Total Funding Raised

$13.91M

Momentum Score

50 /100

Company Overview

Alithea Genomics is a biotechnology company that develops and commercializes massively multiplexed library preparation solutions for RNA sequencing, designed to accelerate drug development and biomarker discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

Bulk RNA Barcoding and sequencingBRB-seqRNA sequencingRNA-seqNGS library preplibrary preparation kitstranscriptomicshigh-throughput sequencinggene expression analysismultiplexed sequencingDRUG-seqbiomarker discoverydrug discoveryRNA barcodingFLASH-seqsingle-cell sequencingbioinformatics solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alithea Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alithea Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMar 4, 2026
SeedMar 14, 2024
DebtMar 27, 2023
SeedMay 24, 2022
GrantApr 28, 2021
Pre Seed
Mar 11, 2021

Key People

Founding team and executive leadership

Stephane Fallot

Chief Financial Officer

Executive Team

Alithea Genomics Investors

Notable investors and investment history

Alithea Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alithea Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alithea Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges
Employee Range33
Year Founded2020
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.